Ignite Creation Date:
2024-05-05 @ 12:02 PM
Last Modification Date:
2024-10-26 @ 9:18 AM
Study NCT ID:
NCT00210197
Status:
COMPLETED
Last Update Posted:
2013-07-26
First Post:
2005-09-13
Brief Title:
Hypercoagulability After Breast Cancer Surgery
Sponsor:
Institut Bergonié
Organization:
Institut Bergonié
Study Overview
Official Title:
Plasma Coagulation Parameters and Hypercoagulability After Breast Cancer Surgery
Status:
COMPLETED
Status Verified Date:
2007-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
EHC
Brief Summary:
The risk of deep venous thrombosis after radical breast surgery is known The objective of this study is to explore hypercoagulability after radical breast cancer surgery by studying several factors for haemostasis before during and after surgery Ultrasound Doppler examination is realised between 24 and 72 hours post-operatively Hypercoagulability is defined by a significant increasing level of thrombin-antithrombin D-dimer and the endogen thrombin potential
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| EHC | None | None | None |